First, we increased or decreased the expression levels of ASS1 in glioma cells using an overexpression plasmid or shRNA and verified the transfection efficiency by qRT-PCR and Western blotting assays (Figure 2a, b). Here, ASS1 is linked to central nervous system cancer.